Clinical Trial Update: Perimenopausal Estrogen Replacement Therapy Study [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating perimenopausal estrogen replacement therapy has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Menopause
• Perimenopause

Drugs mentioned

• Estrogen Replacement Therapy (estrogen replacement therapy)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Perimenopause, Menopause | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-08-22